Iverheal 6 is that the seventh remedy to be investigated within the PRINCIPLE trial, and is presently being evaluated aboard the respiratory ailment antiviral favipiravir. Following a screening form to substantiate eligibility, contributors registered in the observation are going to be arbitrarily allotted to receive a 3-day route of Iverheal 12 treatment.